<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The relationship of bone marrow mast cell counts to prognosis was investigated in 48 patients with preleukaemic <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>, in 59 patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and in a DMBA induced <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>/<z:mpath ids='MPATH_336'>leukaemia</z:mpath> rat model </plain></SENT>
<SENT sid="1" pm="."><plain>In patients with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> terminating in overt <z:mpath ids='MPATH_336'>leukaemia</z:mpath> the number of mast cells per square millimeter was not correlated to duration of the preleukaemic course </plain></SENT>
<SENT sid="2" pm="."><plain><z:mpath ids='MPATH_336'>Leukaemia</z:mpath> development probabilities of patients at risk were not different for low and elevated mast cell counts </plain></SENT>
<SENT sid="3" pm="."><plain>In aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo>, however, a lower bone marrow mast cell count was related to a higher survival probability and longer survival time </plain></SENT>
<SENT sid="4" pm="."><plain>In the animal model no significant differences could be found between myelodysplastic, leukaemic, and control animals </plain></SENT>
</text></document>